OMNIAB, INC. Intangible Assets, Net (Excluding Goodwill)
OMNIAB, INC. (OABI) had Intangible Assets, Net (Excluding Goodwill) of $116.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-06
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $116.07M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $119.12M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $125.15M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $128.38M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2026-06-30 | $116.07M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $119.12M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $125.15M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $128.38M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $131.60M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $134.83M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $138.06M 10-K · filed 2026-03-04 |
| 2024-09-30 | $144.12M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $147.51M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $152.06M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $155.47M 10-K · filed 2025-03-18 |
| 2023-09-30 | $158.77M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $161.92M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $164.35M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $167.24M 10-K · filed 2024-03-25 |
| 2022-11-01 | $166.18M 10-K · filed 2024-03-25 |
| 2021-12-31 | $176.32M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |